Extraordinary General Meeting Called: Business Purpose Expansion and Election of 5 Directors
- An extraordinary general meeting will be held on June 5, 2026, with the record date for voting rights on May 6, 2026.
- Through partial amendment of the articles of incorporation, 20 new business purposes will be added, including pet funeral services, clinical pathology services, overseas medical expansion, non-clinical/clinical trial consulting, and manufacturing/sales of bio-reagents and medical devices. Existing real estate and investment-related business purposes will be systematically reorganized.
- The agenda includes the election of three inside directors (Kim Do-hyung, Kang Woo-hyun, Park Soo-hyun) and two outside directors (Noh Yoon-seok, Kang Jun-gu), each with a three-year term.
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: [Correction of Description] Resolution on Convening of General Meeting of Shareholders (Extraordinary General Meeting)
- Company: ADBIOTECH (179530)
- Submission: ADBIOTECH Co.,Ltd.
- Receipt: 05-21-2026
- Under KRX KOSDAQ Market Division